A rare complication of acute acalculous cholecystitis following abuse of transdermal fentanyl for the treatment of failed back surgery syndrome

被引:0
作者
Hoi Soo Yoon
Kook Jin Chung
机构
[1] Hallym Univerisy Sacred Heart Hospital,Department of Radiology
[2] Hallym University,Department of Orthopaedic Surgery
[3] Kangnam Sacred Heart Hospital,undefined
[4] Hallym University,undefined
来源
European Journal of Orthopaedic Surgery & Traumatology | 2012年 / 22卷
关键词
Complication; Acute acalculous cholecystitis; Transdermal fentanyl patch; Abuse; Failed back surgery syndrome;
D O I
暂无
中图分类号
学科分类号
摘要
A 65-year-old man presented with uncontrolled severe low back pain and both leg pain (VAS 9) due to failed back surgery syndrome confirmed by magnetic resonance imaging. We prescribed transdermal fentanyl patch (25 μg/h) for pain relief, and at 2 weeks later, symptom was lessened (VAS 4). But after 1 month, he was admitted to our emergency department for nausea, vomiting, and right upper quadrant (RUQ) pain occurring 3 days and aggravating 4 h before arrival. He used 2 patches (50 μg/h) without prescription for the purpose of relieving breakthrough pain for 2 weeks. After subsidence of pain, he applied TDF with same dose. On physical examination and radiologic assessment, he was diagnosed as acute acalculous cholecystitis. To the best of authors’ knowledge, there have been no reports about acute acalculous cholecystitis after abuse of TDF. On the diagnosis of acute acalculous cholecystitis (AAC), laparoscopic cholecystectomy was performed. Gangrenous change of GB was found on pathologic specimen. Severe abdominal pain was relieved after surgery. Acute acalculous cholecystitis can occur as a rare complication after abuse of TDF.
引用
收藏
页码:493 / 495
页数:2
相关论文
共 50 条
[1]  
Langford R(2006)Transdermal fentanyl for improvement of pain and functioning in osteoarthritis: a randomized, placebo-controlled trial Arthritis Rheum 54 1829-1837
[2]  
McKenna F(2003)Long-term management of noncancer pain with transdermal therapeutic system-fentanyl J Pain 4 298-306
[3]  
Ratcliffe S(2005)Transdermal fentanyl versus sustained release oral morphine in strong-opioid naïve patients with chronic low back pain Spine 30 2484-2490
[4]  
Vojtassák J(2006)Back pain exacerbations and lost productive time costs in United States workers Spine 31 3052-3060
[5]  
Richarz U(1991)An overview of the incidences and costs of low back pain Orthop Clin N Am 22 263-271
[6]  
Mystakidou K(2007)Back pain in the german adult population: prevalence, severity, and sociodemographic correlates in a multiregional survey Spine 32 2005-2011
[7]  
Parpa E(1996)Chronic opioid analgesic therapy for chronic low back pain J Am Board Fam Pract 9 191-204
[8]  
Tsilika E(2003)Recommendations for using opioids in chronic non-cancer pain Eur J Pain 7 381-386
[9]  
Marvromati A(2000)Duragesic transdermal patch; postmortem tissue distribution of fentanyl in 25 cases J Anal Toxicol 24 627-634
[10]  
Smyrniotis V(1987)The importance of early diagnosis of acute acalculous cholecystitis Surg Gynecol Obstet 164 197-203